Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
Varonis Systems
VRNS
$4.98B
| $241K | ﹤0.01% |
22,716
+8,199
| +56% | +$78.5K |
|
|
HSNI
4052
DELISTED
HSN, Inc.
HSNI
| $241K | ﹤0.01% |
6,501
-3,623
| -36% | -$130K |
|
|
CA
4053
PUT
DELISTED
CA, Inc.
CA
| $241K | ﹤0.01% |
7,600
-1,600
| -17% | -$51.5K |
|
|
RC
4054
Ready Capital
RC
$278M
| $240K | ﹤0.01% |
+16,588
| New | +$226K |
|
|
GTS
4055
DELISTED
Triple-S Management Corporation
GTS
| $240K | ﹤0.01% |
14,405
-5,809
| -29% | -$104K |
|
|
GLOG
4056
DELISTED
GASLOG LTD
GLOG
| $240K | ﹤0.01% |
+15,635
| New | +$250K |
|
|
AMID
4057
DELISTED
American Midstream Partners, LP
AMID
| $240K | ﹤0.01% |
16,207
-5,929
| -27% | -$98.4K |
|
4058
CALL
Cracker Barrel
CBRL
$1.31B
| $239K | ﹤0.01% |
1,500
-4,400
| -75% | -$704K |
|
4059
Central Garden & Pet Co
CENT
$2.76B
| $239K | ﹤0.01% |
8,084
-2,180
| -21% | -$60.2K |
|
4060
Virtus Investment Partners
VRTS
$1.08B
| $239K | ﹤0.01% |
2,253
+704
| +45% | +$78.7K |
|
|
TLRD
4061
CALL
DELISTED
Tailored Brands, Inc.
TLRD
| $239K | ﹤0.01% |
16,000
-3,100
| -16% | -$62.4K |
|
4062
CBIZ
CBZ
$2.97B
| $238K | ﹤0.01% |
17,545
-16,167
| -48% | -$217K |
|
4063
ProShares Ultra Gold
UGL
$709M
| $238K | ﹤0.01% |
24,764
+2,596
| +12% | +$24K |
|
|
SCMP
4064
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $238K | ﹤0.01% |
21,682
-55,503
| -72% | -$644K |
|
|
FTR
4065
CALL
DELISTED
Frontier Communications Corp.
FTR
| $238K | ﹤0.01% |
7,400
+4,633
| +167% | +$212K |
|
4066
Arbutus Biopharma
ABUS
$913M
| $237K | ﹤0.01% |
+72,800
| New | +$202K |
|
4067
PUT
SLM Corp
SLM
$5.16B
| $237K | ﹤0.01% |
+19,600
| New | +$232K |
|
|
ATSG
4068
DELISTED
Air Transport Services Group
ATSG
| $237K | ﹤0.01% |
14,785
-36,321
| -71% | -$592K |
|
|
SPWR
4069
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $237K | ﹤0.01% |
59,248
-27,028
| -31% | -$127K |
|
|
PFPT
4070
DELISTED
Proofpoint, Inc.
PFPT
| $237K | ﹤0.01% |
3,185
-4,700
| -60% | -$374K |
|
|
BKS
4071
DELISTED
Barnes & Noble
BKS
| $237K | ﹤0.01% |
25,676
-25,671
| -50% | -$256K |
|
4072
Ericsson
ERIC
$33B
| $236K | ﹤0.01% |
35,516
-4,376
| -11% | -$27K |
|
4073
PUT
MPLX
MPLX
$60.2B
| $236K | ﹤0.01% |
6,554
+5,573
| +568% | +$205K |
|
4074
PUT
Match Group
MTCH
$8.9B
| $235K | ﹤0.01% |
14,400
-25,600
| -64% | -$438K |
|
|
RRD
4075
CALL
DELISTED
RR Donnelley & Sons Co.
RRD
| $235K | ﹤0.01% |
19,400
+1,734
| +10% | +$27.7K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.